The Company’s headquarters are located at One Commerce Square, 2005 Market Street, Philadelphia, PA 19103.
The Company completed its IPO in February 2020.
Passage Bio stock is traded on the Nasdaq Global Select Market under the ticker PASG.
Computershare Trust Company, N.A. Transfer Agent and Registrar 250 Royall Street Canton, MA 02021
The Company does not currently have a direct stock purchase plan. The Company’s common stock can be purchased by contracting a securities broker of your choice.
Legal counsel: Fenwick & West LLP 555 California Street San Francisco, CA 94104 (415) 875-2300
Auditor: KPMG LLP 1601 Market Street Philadelphia, PA 19103 (267) 256-7000
Corporate news can be found on our Press Releases and Statements page. Quarterly and annual reports, as well as other SEC filings, can be found on our Financials and Filings page or directly from the SEC at www.sec.gov.
Please contact investors@passagebio.com with any additional inquiries.
You can find the latest annual report and proxy statement on our Financials and Filings page or directly from the SEC at www.sec.gov
The date and location of the next annual meeting will be communicated prior to the meeting date.